FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025138253> ?p ?o ?g. }

• W3025138253 endingPage "e0233355" @default.
• W3025138253 startingPage "e0233355" @default.
• W3025138253 abstract "Incarcerated people are at increased risk of human immunodeficiency virus (HIV) infection relative to the general population. Despite a high burden of infection, HIV care use among prison populations is often suboptimal and varies among settings, and little evidence exists explaining the discrepancy. Therefore, this review assessed barriers to optimal use of HIV care cascade in incarcerated people.Quantitative and qualitative studies investigating factors affecting linkage to care, ART (antiretroviral therapy) initiation, adherence and/or outcomes among inmates were systematically searched across seven databases. Studies published in English language and indexed up to 26 October 2018 were reviewed. We performed a narrative review for both quantitative and qualitative studies, and meta-analyses on selected quantitative studies. All retrieved quantitative studies were assessed for risk of bias. Meta-analyses were conducted using RevMan-5 software and pooled odds ratios were calculated using Mantel-Haenszel statistics with 95% confidence interval at a p<0.05. The review protocol has been published at the International Prospective Register of Systematic Reviews (PROSPERO; Number: CRD42019135502).Of forty-two studies included in the narrative review, eight were qualitative studies. Sixteen of the quantitative studies were eligible for meta-analyses. The narrative synthesis revealed structural factors such as: a lack of access to community standard of HIV care, particularly in resource limited countries; loss of privacy; and history of incarceration and re-incarceration as risk factors for poor HIV care use in prison populations. Among social and personal characteristics, lack of social support, stigma, discrimination, substance use, having limited knowledge about, and negative perception towards ART were the main determinants of suboptimal use of care in incarcerated people. In the meta-analyses, lower odds of ART initiation was noticed among inmates with higher baseline CD4 count (CD4 ≥500celss/mm3) (OR = 0.37, 95%CI: 0.14-0.97, I2 = 43%), new HIV diagnosis (OR = 0.07, 95%CI: 0.05-0.10, I2 = 68%), and in those who lacked belief in ART safety (OR = 0.32, 95%CI: 0.18-0.56, I2 = 0%) and efficacy (OR = 0.31, 95%CI: 0.17-0.57, I2 = 0%). Non-adherence was high among inmates who lacked social support (OR = 3.36, 95%CI: 2.03-5.56, I2 = 35%), had low self-efficiency score (OR = 2.50, 95%CI: 1.64,-3.80, I2 = 22%) and those with depressive symptoms (OR = 2.02, 95%CI: 1.34-3.02, I2 = 0%). Lower odds of viral suppression was associated with history of incarceration (OR = 0.40, 95%CI: 0.35-0.46, I2 = 0%), re-incarceration (OR = 0.09, 95%CI: 0.06-0.13, I2 = 64%) and male gender (OR = 0.55, 95%CI: 0.42-0.72, I2 = 0%). Higher odds of CD4 count <200cells/mm3 (OR = 2.01, 95%CI: 1.62, 2.50, I2 = 44%) and lower odds of viral suppression (OR = 0.20, 95%CI: 0.17-0.22, I2 = 0%) were observed during prison entry compared to those noticed during release.Given the high HIV risk in prison populations and rapid movements of these people between prison and community, correctional facilities have the potential to substantially contribute to the use of HIV treatment as a prevention strategy. Thus, there is an urgent need for reviewing context specific interventions and ensuring standard of HIV care in prisons, particularly in resource limited countries." @default.
• W3025138253 created "2020-05-21" @default.
• W3025138253 creator A5011934571 @default.
• W3025138253 creator A5049500926 @default.
• W3025138253 creator A5065341496 @default.
• W3025138253 date "2020-05-18" @default.
• W3025138253 modified "2023-10-09" @default.
• W3025138253 title "A systematic review and meta-analyses on initiation, adherence and outcomes of antiretroviral therapy in incarcerated people" @default.
• W3025138253 cites W1724978910 @default.
• W3025138253 cites W1913941933 @default.
• W3025138253 cites W1941971088 @default.
• W3025138253 cites W1974559768 @default.
• W3025138253 cites W1976172257 @default.
• W3025138253 cites W1992751687 @default.
• W3025138253 cites W1997811579 @default.
• W3025138253 cites W1999996920 @default.
• W3025138253 cites W2003495348 @default.
• W3025138253 cites W2004691066 @default.
• W3025138253 cites W2007888740 @default.
• W3025138253 cites W2010669458 @default.
• W3025138253 cites W2022863092 @default.
• W3025138253 cites W2023057695 @default.
• W3025138253 cites W2025655819 @default.
• W3025138253 cites W2033905021 @default.
• W3025138253 cites W2034867640 @default.
• W3025138253 cites W2071931802 @default.
• W3025138253 cites W2071971809 @default.
• W3025138253 cites W2091056769 @default.
• W3025138253 cites W2091576053 @default.
• W3025138253 cites W2092946317 @default.
• W3025138253 cites W2093062350 @default.
• W3025138253 cites W2096329396 @default.
• W3025138253 cites W2097420075 @default.
• W3025138253 cites W2106853339 @default.
• W3025138253 cites W2109231981 @default.
• W3025138253 cites W2110800847 @default.
• W3025138253 cites W2111804185 @default.
• W3025138253 cites W2117718259 @default.
• W3025138253 cites W2121857020 @default.
• W3025138253 cites W2125435699 @default.
• W3025138253 cites W2128489201 @default.
• W3025138253 cites W2138826013 @default.
• W3025138253 cites W2145226606 @default.
• W3025138253 cites W2148221009 @default.
• W3025138253 cites W2155713195 @default.
• W3025138253 cites W2159769773 @default.
• W3025138253 cites W2161374186 @default.
• W3025138253 cites W2161884517 @default.
• W3025138253 cites W2180006680 @default.
• W3025138253 cites W2193003008 @default.
• W3025138253 cites W2199362826 @default.
• W3025138253 cites W2202681372 @default.
• W3025138253 cites W2211524874 @default.
• W3025138253 cites W2277099286 @default.
• W3025138253 cites W2277570810 @default.
• W3025138253 cites W2399908460 @default.
• W3025138253 cites W2416738403 @default.
• W3025138253 cites W2426257378 @default.
• W3025138253 cites W2444486975 @default.
• W3025138253 cites W2466193146 @default.
• W3025138253 cites W2488579943 @default.
• W3025138253 cites W2509671514 @default.
• W3025138253 cites W2513221909 @default.
• W3025138253 cites W2517757474 @default.
• W3025138253 cites W2529963508 @default.
• W3025138253 cites W2560220722 @default.
• W3025138253 cites W2580245911 @default.
• W3025138253 cites W2580311219 @default.
• W3025138253 cites W2601453889 @default.
• W3025138253 cites W2743968283 @default.
• W3025138253 cites W2782847725 @default.
• W3025138253 cites W2802083998 @default.
• W3025138253 cites W2804970144 @default.
• W3025138253 cites W2889351344 @default.
• W3025138253 cites W2895361428 @default.
• W3025138253 cites W2955273711 @default.
• W3025138253 cites W69587150 @default.
• W3025138253 cites W1994650218 @default.
• W3025138253 doi "https://doi.org/10.1371/journal.pone.0233355" @default.
• W3025138253 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7233580" @default.
• W3025138253 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32421754" @default.
• W3025138253 hasPublicationYear "2020" @default.
• W3025138253 type Work @default.
• W3025138253 sameAs 3025138253 @default.
• W3025138253 citedByCount "17" @default.
• W3025138253 countsByYear W30251382532021 @default.
• W3025138253 countsByYear W30251382532022 @default.
• W3025138253 countsByYear W30251382532023 @default.
• W3025138253 crossrefType "journal-article" @default.
• W3025138253 hasAuthorship W3025138253A5011934571 @default.
• W3025138253 hasAuthorship W3025138253A5049500926 @default.
• W3025138253 hasAuthorship W3025138253A5065341496 @default.
• W3025138253 hasBestOaLocation W30251382531 @default.
• W3025138253 hasConcept C118552586 @default.
• W3025138253 hasConcept C126322002 @default.
• W3025138253 hasConcept C144024400 @default.
• W3025138253 hasConcept C156957248 @default.
• W3025138253 hasConcept C15744967 @default.

• next